Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Renal Cell Carcinoma Post-nephrectomy in the United States
Lists
Only you see this
BibTeX
@inproceedings{lai2023cost,
author = {Yizhen Lai and Arielle G. Bensimon and Emily Gao and Rituparna Bhattacharya and Ruifeng Xu and Jestinah Chevure and Kentaro Imai and Naomi B. Haas},
title = {{Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Renal Cell Carcinoma Post-nephrectomy in the United States}},
booktitle = {Clinical},
year = {2023},
doi = {10.1016/j.clgc.2023.03.016},
}Loading related content...